|
Market Closed -
Euronext Paris
09:25:00 19/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.200 EUR | +2.33% |
|
-0.90% | -18.82% |
| 01/10 | Taconic Biosciences, Inc. And genOway Partner To Expand U.S. Access To Advanced Humanized Mouse Models | CI |
| 23/09 | GenOway teams up with Taconic Biosciences to accelerate in the United States |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.23Cr | - | - | - | - | - |
| 6.5TCr | |||||
| 5.12TCr | |||||
| 5.12TCr | |||||
| 4.39TCr | |||||
| 4.2TCr |
- Stock Market
- Stocks
- ALGEN Stock
- Charts genOway
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
